CHERRY HILL, N.J., April 29, 2026 /PRNewswire/ -- The Multiple Sclerosis Association of America (MSAA) is proud to announce our 12th Improving Lives Benefit, in support of the multiple sclerosis ...

Turkey’s parliament approved a law on Wednesday to drop a requirement for companies to produce inflation-adjusted accounts for the 2025, 2026 and 2027 financial years. Countries sometimes employ ...

AstraZeneca today announced a strategic regional collaboration with the Middle East North Africa Committee for Treatment and Research in Multiple Sclerosis (MENACTRIMS) to implement AI-enabled brain ...

GE HealthCare GEHC has recently announced plans to acquire Belgium-based icometrix, a company specializing in AI-powered brain imaging solutions, in a move designed to advance its precision care ...

CHICAGO - GE HealthCare (NASDAQ:GEHC), a prominent player in the Healthcare Equipment & Supplies industry with a market capitalization of $35.94 billion, announced Wednesday that it has entered into ...

The anticipated acquisition aligns with GE HealthCare’s precision care strategy with the goal of strengthening the company’s portfolio of offerings in neurological care and its quantitative analysis ...

GE HealthCare said that, with the recent approvals of new anti-amyloid therapies, patients with Alzheimer’s disease may need more frequent MRI scans to track the progress and safety of their regimens.

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. GE HealthCare said this morning it has entered into an ...

Icometrix's icobrain aria is claimed to be the first US Food and Drug Administration (FDA)-cleared AI solution for detecting and quantifying Amyloid-Related Imaging Abnormalities (ARIA). Image credit: ...

GE HealthCare (Nasdaq: GEHC) today announced it has entered into an agreement to acquire icometrix, a company focused on providing AI-powered brain imaging analysis for neurological disorders such as ...